semaglutide gastric intestinal obstruction lawyer in michigan At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning America." Ozempic® Lawsuit | July 2026
Description
The WHO released its first global guideline for GLP-1 obesity treatment, recognizing obesity as a chronic disease
In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.
Immobilized Human GLP-1R, mFc Tag at 1 g/ml (100 l/well) on the plate
In Truveta Research's latest GLP-1 RA prescribing trends report, tirzepatide is now the most-prescribed GLP-1 RA medication.
These medications are everywhere right nowon the news, in gym conversations, and even debated in doctors offices
Oral alternative to injectable semaglutide
